subject: Crohn's Disease - Drug Pipeline Analysis And Market Forecasts To 2015---aarkstore Enterprise Market [print this page] Summary Summary
The industry analysis specialists new report, Crohns Disease Drug Pipeline Analysis and Market Forecasts to 2015 is an essential source of information and analysis on the global Crohns disease market. The report identifies the key trends shaping and driving the global Crohns disease market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global Crohns disease sector.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalDatas team of industry experts.
Scope
The scope of the report includes:
- Annualized global Crohns disease market revenues data from 2000 to 2008, forecast forward for 7 years to 2015.
- Geographies covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.
- Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends. Key classes of mechanism of action includes TNF-alpha inhibitor, IL-12 and 23 inhibitor, IL-6 inhibitor, IL-17 inhibitor, chemokine receptor inhibitor, Co stimulation modulator, Anti CD3 molecules, Anti MAP agent, Cell adhesion molecule inhibitor, Oral adsorbents, Other immunosupressors, Stem cell therapy.
- Analysis of the current and future market competition in the global Crohns disease market. Key market players covered are Chemocentryx Inc., Bristol-Myers Squibb, Abbott laboratories and Johnson & Johnson.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with Crohns disease.
